HIV-1 subtypes and drug-resistance mutation sites in HIV/AIDS patients with antiretroviral-therapy failure

Journal Title: Shanghai Journal of Preventive Medicine - Year 2023, Vol 35, Issue 3

Abstract

ObjectiveTo analyze the characteristics of HIV-1 subtypes and drug-resistance mutation sites among HIV-infected patients who received high-efficiency antiretroviral therapy but failed.MethodsA total of 130 plasma samples were collected from the patients who received antiviral treatment for 6 months in Taizhou City of Zhejiang Province in 2021 but failed the treatment and the viral load was ≥1 000 copies·mL-1. Nucleic acid in the samples was extracted, and the pol gene was amplified by nested reverse transcription PCR. After next-generation sequencing, online tools were used to compare and analyze the subtypes and drug-resistant mutation sites.ResultsA total of 110 samples were successfully sequenced. The main HIV-1 subtype was CRF01_AE, accounting for 42.72% (47 cases), followed by CRF07_BC, 35.45% (39 cases); CRF08_BC, 10.00% (11 cases); CRF85_BC , 8.18% (9); and a small number of B subtype, 1.81% (2 cases) and C subtype, 1.81% (2 cases). The online tool comparison showed that there were 67 cases with mutations of drug-resistance sites and 61 cases with drug-resistance. The mutation sites were mainly M184V, K103N, K65R and V181C, and the mutation rates were 20.00% (22 cases), 10.91% (12 cases), 8.18% (9 cases) and 8.18% (9 cases), respectively. These mutation sites caused different degrees of resistance to nucleoside reverse transcriptase inhibitors (NRTI), non- nucleoside reverse transcriptase inhibitors (NNRTI) and protease inhibitors (PI), including 45 cases of NRTI, 61 cases of NNRTI and 2 cases of PI resistance.ConclusionThe HIV infected people who fail the treatment in Taizhou are mainly with the subtypes CRF01_AE and CRF07_BC. The rate of drug-resistance mutation is at a moderate level, mainly due to the mutation of NRTI and NNRTI drug-resistance sites, and a small number of PI drug-resistance sites. Therefore, the antiviral treatment plan for HIV infected people should be reasonably adjusted, and the detection of drug-resistance mutation sites should be strengthened to avoid the generation of transmissible drug-resistance strains.

Authors and Affiliations

LIN Junxiao,WANG Hongzhu,LI Congcong,SHENG Ying,LI Guixia,

Keywords

Related Articles

Heavy metal pollution of soil and chronic diseases among residents around an abandoned rare earth ore in Jiangxi

ObjectiveTo understand the distribution characteristics of soil metal pollution around an abandoned rare earth ore in Jiangxi and the health impact on the surrounding residents.MethodsAccording to the distribution of aba...

Air quality monitoring and correlation analysis in public areas of three subway stations in Shanghai

ObjectiveTo understand the correlation between air quality and pollutants in three underground subway stations in Shanghai and their influencing factors, in order to provide a reference for improving the ambient air qu...

A bibliometric analysis of literatures in terms of WHO maternal morbidity definition

ObjectiveThis study used bibliometrics to analyze the global application and research progress of the new WHO maternal morbidity definition.MethodsA Total of 13 literatures published by WHO-MMWG since 2013 were collected...

A study of factors influencing the willingness of primary healthcare workers in Qinghai Province to engage in non-discriminatory behaviors towards HBV-infected patients

ObjectiveTo understand the current status of primary healthcare workers’ knowledge of hepatitis B and their willingness to engage in non-discriminatory behaviors, to explore the factors influencing their willingnessï...

Investigation of infestation and disposal of bedbugs in Shanghai

Objective To investigate the infestation and disposal of bedbugs in Shanghai, and provide scientific evidence for comprehensive prevention and control of bedbugs.Methods A questionnaire survey was conducted in the pest...

Download PDF file
  • EP ID EP742089
  • DOI -
  • Views 28
  • Downloads 0

How To Cite

LIN Junxiao, WANG Hongzhu, LI Congcong, SHENG Ying, LI Guixia, (2023). HIV-1 subtypes and drug-resistance mutation sites in HIV/AIDS patients with antiretroviral-therapy failure. Shanghai Journal of Preventive Medicine, 35(3), -. https://www.europub.co.uk/articles/-A-742089